Enzyme-Linked Immunosorbent Assay (ELISA) Industry Research Report 2024

Enzyme-Linked Immunosorbent Assay (ELISA) Industry Research Report 2024


Summary

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples—serum, plasma, cell culture supernatants and cell lysates—indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
According to APO Research, The global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Enzyme-Linked Immunosorbent Assay (ELISA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Enzyme-Linked Immunosorbent Assay (ELISA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Enzyme-Linked Immunosorbent Assay (ELISA) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Enzyme-Linked Immunosorbent Assay (ELISA) include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences and BioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (ELISA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (ELISA).
The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enzyme-Linked Immunosorbent Assay (ELISA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

R&D Systems
Thermo Fisher Scientific
Ortho Clinical Diagnostics
BD Biosciences
ZEUS Scientific
Bio-Rad Laboratories
ALPCO
Enzo Life Sciences
BioMérieux
EMD Millipore
BioLegend
LOEWE Biochemica
Mercodia
Cusabio
Shanghai Kehua Bio-engineering
Enzyme-Linked Immunosorbent Assay (ELISA) segment by Type

Sandwich ELISA
Indirect ELISA
Competitive ELISA
Others
Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Application

Immunology
Inflammation
Infectious Diseases
Cancer
Protein Quantitation
Others
Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Region

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Enzyme-Linked Immunosorbent Assay (ELISA) by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Sandwich ELISA
2.2.3 Indirect ELISA
2.2.4 Competitive ELISA
2.2.5 Others
2.3 Enzyme-Linked Immunosorbent Assay (ELISA) by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Immunology
2.3.3 Inflammation
2.3.4 Infectious Diseases
2.3.5 Cancer
2.3.6 Protein Quantitation
2.3.7 Others
2.4 Assumptions and Limitations
3 Enzyme-Linked Immunosorbent Assay (ELISA) Breakdown Data by Type
3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size by Type (2019-2024)
3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Forecasted Market Size by Type (2025-2030)
4 Enzyme-Linked Immunosorbent Assay (ELISA) Breakdown Data by Application
4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size by Application (2019-2024)
4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Forecasted Market Size by Application (2019-2024)
5 Global Growth Trends
5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Perspective (2019-2030)
5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Growth Trends by Region
5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Historic Market Size by Region (2019-2024)
5.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Forecasted Market Size by Region (2025-2030)
5.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Dynamics
5.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
5.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
5.3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Challenges
5.3.4 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Enzyme-Linked Immunosorbent Assay (ELISA) Players by Revenue
6.1.1 Global Top Enzyme-Linked Immunosorbent Assay (ELISA) Players by Revenue (2019-2024)
6.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Players (2019-2024)
6.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Enzyme-Linked Immunosorbent Assay (ELISA) Head office and Area Served
6.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players, Product Type & Application
6.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Players, Date of Enter into This Industry
6.6 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2019-2030)
7.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2019-2024)
7.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2019-2030)
8.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2019-2024)
8.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2019-2030)
9.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2019-2024)
9.4 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 Latin America
10.1 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2019-2030)
10.2 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2019-2024)
10.4 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size (2019-2030)
11.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2019-2024)
11.4 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 Players Profiled
12.1 R&D Systems
12.1.1 R&D Systems Company Information
12.1.2 R&D Systems Business Overview
12.1.3 R&D Systems Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.1.4 R&D Systems Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.1.5 R&D Systems Recent Developments
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Company Information
12.2.2 Thermo Fisher Scientific Business Overview
12.2.3 Thermo Fisher Scientific Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.2.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.2.5 Thermo Fisher Scientific Recent Developments
12.3 Ortho Clinical Diagnostics
12.3.1 Ortho Clinical Diagnostics Company Information
12.3.2 Ortho Clinical Diagnostics Business Overview
12.3.3 Ortho Clinical Diagnostics Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.3.4 Ortho Clinical Diagnostics Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.3.5 Ortho Clinical Diagnostics Recent Developments
12.4 BD Biosciences
12.4.1 BD Biosciences Company Information
12.4.2 BD Biosciences Business Overview
12.4.3 BD Biosciences Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.4.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.4.5 BD Biosciences Recent Developments
12.5 ZEUS Scientific
12.5.1 ZEUS Scientific Company Information
12.5.2 ZEUS Scientific Business Overview
12.5.3 ZEUS Scientific Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.5.4 ZEUS Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.5.5 ZEUS Scientific Recent Developments
12.6 Bio-Rad Laboratories
12.6.1 Bio-Rad Laboratories Company Information
12.6.2 Bio-Rad Laboratories Business Overview
12.6.3 Bio-Rad Laboratories Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.6.4 Bio-Rad Laboratories Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.6.5 Bio-Rad Laboratories Recent Developments
12.7 ALPCO
12.7.1 ALPCO Company Information
12.7.2 ALPCO Business Overview
12.7.3 ALPCO Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.7.4 ALPCO Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.7.5 ALPCO Recent Developments
12.8 Enzo Life Sciences
12.8.1 Enzo Life Sciences Company Information
12.8.2 Enzo Life Sciences Business Overview
12.8.3 Enzo Life Sciences Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.8.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.8.5 Enzo Life Sciences Recent Developments
12.9 BioMérieux
12.9.1 BioMérieux Company Information
12.9.2 BioMérieux Business Overview
12.9.3 BioMérieux Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.9.4 BioMérieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.9.5 BioMérieux Recent Developments
12.10 EMD Millipore
12.10.1 EMD Millipore Company Information
12.10.2 EMD Millipore Business Overview
12.10.3 EMD Millipore Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.10.4 EMD Millipore Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.10.5 EMD Millipore Recent Developments
12.11 BioLegend
12.11.1 BioLegend Company Information
12.11.2 BioLegend Business Overview
12.11.3 BioLegend Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.11.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.11.5 BioLegend Recent Developments
12.12 LOEWE Biochemica
12.12.1 LOEWE Biochemica Company Information
12.12.2 LOEWE Biochemica Business Overview
12.12.3 LOEWE Biochemica Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.12.4 LOEWE Biochemica Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.12.5 LOEWE Biochemica Recent Developments
12.13 Mercodia
12.13.1 Mercodia Company Information
12.13.2 Mercodia Business Overview
12.13.3 Mercodia Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.13.4 Mercodia Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.13.5 Mercodia Recent Developments
12.14 Cusabio
12.14.1 Cusabio Company Information
12.14.2 Cusabio Business Overview
12.14.3 Cusabio Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.14.4 Cusabio Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.14.5 Cusabio Recent Developments
12.15 Shanghai Kehua Bio-engineering
12.15.1 Shanghai Kehua Bio-engineering Company Information
12.15.2 Shanghai Kehua Bio-engineering Business Overview
12.15.3 Shanghai Kehua Bio-engineering Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Business (2019-2024)
12.15.4 Shanghai Kehua Bio-engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
12.15.5 Shanghai Kehua Bio-engineering Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings